James J. Mullen, III
Morrison & Foerster LLP
Articles
Podcast: Unpacking the Science and Legal Considerations of COVID-19 Testing
USA - October 13 2020 In this first of a four-part podcast series on the science, regulatory framework, commercial transactions, and privacy and data security…
Bethany J. Hills, Matthew Karlyn, Kristen J. Mathews, Michael R. Ward
Federal Circuit Corrects USPTO on Reasonable Efforts When Calculating Patent Term Adjustment
USA - January 25 2019 The Federal Circuit ruled on January 23, 2019, that the United States Patent and Trademark Office (“PTO”) erred in reducing the term of a patent owned…
Patent Eligibility in the Life Sciences: Supreme Court Declines Review of Ariosa Diagnostics v. Sequenom
USA - June 30 2016 On June 27, 2016, the U.S. Supreme Court denied certiorari in Ariosa Diagnostics, Inc. v. Sequenom, Inc., thereby letting stand the Federal Circuit's…
USPTO Issues New Subject Matter Eligibility Examples for Life Sciences
USA - May 12 2016 The United States Patent and Trademark Office (USPTO) recently provided updated guidance regarding the patent eligibility of subject matter related…
No more isolated DNA patents, the Supreme Court rules
USA - June 13 2013 In a unanimous decision, the U.S. Supreme Court today ruled that naturally occurring, isolated human gene sequences are a product of nature, and thus…
